ENDOTHELIAL-CELL PRESERVATION USING ORGAN STORAGE SOLUTIONS

被引:40
作者
KILLINGER, WA [1 ]
DOROFI, DB [1 ]
KEAGY, BA [1 ]
JOHNSON, G [1 ]
机构
[1] UNIV N CAROLINA,SCH MED,DEPT SURG,210 BURNETT WOMACK,CAMPUS BOX 7210,CHAPEL HILL,NC 27599
关键词
D O I
10.1097/00007890-199205000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of organ preservation solutions has been primarily accomplished in whole organ animal models. This study examines the toxicity of commonly used organ preservation solutions on endothelial cells in vitro. Primary human umbilical-vein endothelial cell cultures were incubated at 4-degrees-C in solutions of 0.9% saline (NS), EuroCollins, ViaSpan (Belzer UW) (VIA), or Hank's balanced salts with 5% polyethylene glycol (PEG). Endothelial cell viability was ascertained by colormetric measurement of mitochondrial reduction of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to purple 1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan. After exposure to hypothermic storage, cells were incubated at 37-degrees-C in media with MTT, and the amount of reduced formazan present was quantified using a micro-ELISA spectrophotometer. Higher absorbance values were indicative of better cellular preservation. Cells stored in PEG displayed the highest viability at all time periods. ViaSpan provided better cellular protection than EC at longer storage intervals. This model allows for rapid assessment of preservation-induced endothelial cell injury and may aid development of improved storage techniques.
引用
收藏
页码:979 / 982
页数:4
相关论文
共 19 条
[1]   THE BASIS FOR TOXICITY OF CERTAIN CRYOPROTECTANTS - A HYPOTHESIS [J].
ARAKAWA, T ;
CARPENTER, JF ;
KITA, YA ;
CROWE, JH .
CRYOBIOLOGY, 1990, 27 (04) :401-415
[2]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[3]  
DALESSANDRO AM, 1991, ARCH PATHOL LAB MED, V155, P306
[4]  
DANIEL MR, 1976, BRIT J EXP PATHOL, V57, P137
[5]  
FRESHNEY RI, 1987, CULTURE ANIMAL CELLS, P246
[6]   NATIONAL ALLOCATION OF CADAVERIC KIDNEYS BY HLA MATCHING - PROJECTED EFFECT ON OUTCOME AND COSTS [J].
GJERTSON, DW ;
TERASAKI, PI ;
TAKEMOTO, S ;
MICKEY, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) :1032-1036
[7]   RAPID COLORMETRIC ASSAY FOR CELL VIABILITY - APPLICATION TO THE QUANTITATION OF CYTO-TOXIC AND GROWTH INHIBITORY LYMPHOKINES [J].
GREEN, LM ;
READE, JL ;
WARE, CF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 70 (02) :257-268
[8]   A COMPARISON OF SOLUTIONS FOR LUNG PRESERVATION USING PULMONARY ALVEOLAR TYPE-II CELL VIABILITY [J].
HACHIDA, M ;
HOON, DSB ;
MORTON, DL .
ANNALS OF THORACIC SURGERY, 1988, 45 (06) :643-646
[9]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[10]   EFFECT OF POLYETHYLENE-GLYCOL ON LIPID-PEROXIDATION IN COLD-STORED RAT HEPATOCYTES [J].
MACK, JE ;
KERR, JA ;
VREUGDENHIL, PK ;
BELZER, FO ;
SOUTHARD, JH .
CRYOBIOLOGY, 1991, 28 (01) :1-7